Literature DB >> 12857973

HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages.

Bruce D Freedman1, Qing-Hua Liu, Manuela Del Corno, Ronald G Collman.   

Abstract

The chemokine receptors CCR5 and CXCR4 serve as the cellular receptors in conjunction with CD4 for HIV-1 entry and infection of target cells. Although the virus has subverted these molecules for its own use, their natural function is to respond to activation and migration signals delivered by extracellular chemokines. A principal research objective of our laboratory is to understand the consequences of virus-chemokine receptor interactions for cellular function, as well as for entry and infection. We hypothesized that CXCR4-using (X4) and CCR5-using (R5) HIV-1 strains might elicit signals through the chemokine receptors that result in aberrant function and/or regulate virus entry or postentry steps of infection. We have focused on primary human macrophages, which express both CXCR4 and CCR5, because macrophages are a principal target for HIV-1 in vivo, inappropriate macrophage activation appears to play a major role in the pathogenesis of certain sequelae of AIDS, such as HIV encephalopathy, and macrophage infection is regulated at several steps subsequent to entry in ways that are linked to envelope- receptor interactions. This review summarizes our recent findings regarding the mechanisms of chemokine-receptor signaling in macrophages, the role of viral envelope glycoproteins in eliciting macrophage signals, and how these activation pathways may participate in macrophage infection and affect cell functions apart from infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857973     DOI: 10.1385/IR:27:2-3:261

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  85 in total

1.  Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.

Authors:  C K Lapham; M B Zaitseva; S Lee; T Romanstseva; H Golding
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

2.  Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.

Authors:  A L Edinger; A Amedee; K Miller; B J Doranz; M Endres; M Sharron; M Samson; Z H Lu; J E Clements; M Murphey-Corb; S C Peiper; M Parmentier; C C Broder; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.

Authors:  Y Sotsios; G C Whittaker; J Westwick; S G Ward
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome.

Authors:  S A Lipton; H E Gendelman
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

Review 5.  Opportunistic infections of the central nervous system during HIV-1 infection (emphasis on cytomegalovirus disease).

Authors:  E Roullet
Journal:  J Neurol       Date:  1999-04       Impact factor: 4.849

6.  Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.

Authors:  Z Chen; P Zhou; D D Ho; N R Landau; P A Marx
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8.

Authors:  M R Capobianchi; C Barresi; P Borghi; S Gessani; L Fantuzzi; F Ameglio; F Belardelli; S Papadia; F Dianzani
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry.

Authors:  F Kirchhoff; S Pöhlmann; M Hamacher; R E Means; T Kraus; K Uberla; P Di Marzio
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Phagocytosis by human macrophages is accompanied by changes in ionic channel currents.

Authors:  C Ince; J M Coremans; D L Ypey; P C Leijh; A A Verveen; R van Furth
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

10.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.

Authors:  M I Bukrinsky; H S Nottet; H Schmidtmayerova; L Dubrovsky; C R Flanagan; M E Mullins; S A Lipton; H E Gendelman
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  20 in total

1.  Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

Authors:  E A Nickoloff-Bybel; P Mackie; K Runner; S M Matt; H Khoshbouei; P J Gaskill
Journal:  Brain Behav Immun       Date:  2019-08-27       Impact factor: 7.217

2.  R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells.

Authors:  Claudia Cicala; James Arthos; Elena Martinelli; Nina Censoplano; Catherine C Cruz; Eva Chung; Sara M Selig; Donald Van Ryk; Jun Yang; Shyla Jagannatha; Tae Wook Chun; Ping Ren; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  Transcriptome analysis of monocyte-HIV interactions.

Authors:  Rafael Van den Bergh; Eric Florence; Erika Vlieghe; Tom Boonefaes; Johan Grooten; Erica Houthuys; Huyen Thi Thanh Tran; Youssef Gali; Patrick De Baetselier; Guido Vanham; Geert Raes
Journal:  Retrovirology       Date:  2010-06-14       Impact factor: 4.602

4.  The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.

Authors:  Tzanko S Stantchev; Ingrid Markovic; William G Telford; Kathleen A Clouse; Christopher C Broder
Journal:  Virus Res       Date:  2006-10-09       Impact factor: 3.303

5.  Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

Authors:  Laura Fantuzzi; Francesca Spadaro; Cristina Purificato; Serena Cecchetti; Franca Podo; Filippo Belardelli; Sandra Gessani; Carlo Ramoni
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

6.  Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage.

Authors:  Woong-Ki Kim; Yue Sun; Hien Do; Patrick Autissier; Elkan F Halpern; Michael Piatak; Jeffrey D Lifson; Tricia H Burdo; Michael S McGrath; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

7.  Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal-specific tubulin.

Authors:  Valeria Avdoshina; Francesca Taraballi; Simona Dedoni; Claudia Corbo; Mikell Paige; Yasemin Saygideğer Kont; Aykut Üren; Ennio Tasciotti; Italo Mocchetti
Journal:  J Neurochem       Date:  2016-03-15       Impact factor: 5.372

Review 8.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

9.  Constitutively active CCR5 chemokine receptors differ in mediating HIV envelope-dependent fusion.

Authors:  Alex de Voux; Mei-Chi Chan; Asongna T Folefoc; Michael T Madziva; Colleen A Flanagan
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivo.

Authors:  Lee D Major; Thomas S Partridge; Joy Gardner; Stephen J Kent; Robert de Rose; Andreas Suhrbier; Wayne A Schroder
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.